In this trial of >18K patients with ACS, they were randomized to ticagrelor (an oral reversible direct inhibitor of adenosine diphosphate) or clopidogrel. At 1 year, rates of MI/CVA/Vascular death were lower in the ticagrelor group (10%) than the clopidogrel group (12%) with no difference in overall bleeding (abstract). Ticagrelor is superior to clopidogrel in reducing events post-ACS, and is pending FDA approval.
The question of appropriate ward garb is a problem for the ages. Compared to photo stills and films from the 1960s, the doctors of today appear like vagabonds. No ties, no lab coats, and scrub tops have become the norm for a number (a majority ?) of hospital-based docs—and even more so on the surgical […]
Prices from a chargemaster are “what a drunken billionaire would pay a hospital if his wife were not around to control the bastard.” — Uwe Reinhardt You might be asking why such an outlandish quote? Last week CMS proposed* to change the way patients see the costs of hospital bills. So what you might utter. […]
“Membership in the American Academy of Professional Coders has risen to more than 170,000 today from roughly 70,000 in 2008.” “The AMA owns the copyright to CPT, the code used by doctors. It publishes coding books and dictionaries. It also creates new codes when doctors want to charge for a new procedure. It levies a […]